OverviewSuggest Edit

    Poxel, a research integrated pharmaceutical company, engages in developing products for metabolic diseases with a focus on Type 2 diabetes. It offers Imeglimin, an orally active adjunct for diet and exercises to improve glycemic control in patients with type 2 diabetes; Glucagon-like peptide-1 receptor agonist, an incretin hormone displaying glucose-dependent stimulation of insulin secretion and restoring the normal profile of insulin release in response to glucose; and AMP-activated protein kinase activator, an enzyme that controls whole-body energy metabolism by regulating glucose and fatty acid homeostasis in various peripheral tissues, such as skeletal muscle and liver. 
    HQLyon, FR
    Employee Ratings0

    Latest Updates

    Employees (est.) (Feb 2019)34(+36%)

    Key People/Management at Poxel

    Thomas Kuhn

    Thomas Kuhn

    CEO, Co-Founder

    Poxel Office Locations

    Poxel has an office in Lyon
    Lyon, FR (HQ)
    200 Avenue Jean Jaures
    Show all (1)

    Poxel News and Updates

    Poxel Frequently Asked Questions

    • When was Poxel founded?

      Poxel was founded in 2009.

    • Who are Poxel key executives?

      Poxel's key executives are Thomas Kuhn.

    • How many employees does Poxel have?

      Poxel has 34 employees.

    • Who are Poxel competitors?

      Competitors of Poxel include Promethera Biosciences, RaySearch Laboratories and GNS Healthcare.

    • Where is Poxel headquarters?

      Poxel headquarters is located at 200 Avenue Jean Jaures, Lyon.

    • Where are Poxel offices?

      Poxel has an office in Lyon.

    • How many offices does Poxel have?

      Poxel has 1 office.